Schedule 13G ownership disclosure
SCILEX HOLDING CO
Common Stock par value $0.0001 per share · CUSIP: 80880W205
Event date: 2025-06-30
- Filing-level shares
- 764,277.00
- Percent of class
- 9.9%
- Oramed Pharmaceuticals Inc.
Shares: 764,277.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-076929
- Form type
- SCHEDULE 13G/A
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership